These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6297384)

  • 1. Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; van den Berg JC; Michel MF
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1042-50. PubMed ID: 6297384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of in vitro antibacterial activities of cefotiam and cefazolin to their therapeutic effects on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
    Nishi T; Nakao M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Feb; 34(2):231-9. PubMed ID: 6271719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; van den Berg JC; Vree TB; Baars AM; Michel MF
    Antimicrob Agents Chemother; 1985 Nov; 28(5):654-9. PubMed ID: 3911879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacies of ceftazidime and cefepime in rats with experimental pneumonia caused by extended-spectrum beta-lactamase-producing strain of Klebsiella pneumonia].
    Wang WF; Liu YN; She DY
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):390-4. PubMed ID: 17045021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1809-15. PubMed ID: 3324962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
    Nishi T; Tsuchiya K
    Antimicrob Agents Chemother; 1980 Oct; 18(4):549-56. PubMed ID: 7004342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berg JC; Michel MF
    J Infect Dis; 1985 Aug; 152(2):373-8. PubMed ID: 3897395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo morphological response of Klebsiella pneumoniae to cefotiam and cefazolin.
    Nakao M; Nishi T; Tsuchiya K
    Antimicrob Agents Chemother; 1981 May; 19(5):901-10. PubMed ID: 6271051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S33-40. PubMed ID: 3325928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ceftazidime in experimental Klebsiella pneumoniae pneumonia: comparison with other antibiotics and measurement of its penetration into respiratory tissues and secretions.
    McColm AA; Shelley E; Ryan DM; Acred P
    J Antimicrob Chemother; 1986 Nov; 18(5):599-608. PubMed ID: 3542926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Petraitiene R; Petraitis V; Kavaliauskas P; Maung BBW; Khan F; Naing E; Aung T; Zigmantaite V; Grigaleviciute R; Kucinskas A; Stakauskas R; Georgiades BN; Mazur CA; Hayden JA; Satlin MJ; Walsh TJ
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015048
    [No Abstract]   [Full Text] [Related]  

  • 12. Cefodizime, an aminothiazolyl cephalosporin. III. Therapeutic activity against experimentally induced pneumonia in mice.
    Klesel N; Limbert M; Seibert G; Winkler I; Schrinner E
    J Antibiot (Tokyo); 1984 Dec; 37(12):1712-8. PubMed ID: 6098572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.
    Fournier JL; Ramisse F; Jacolot AC; Szatanik M; Petitjean OJ; Alonso JM; Scavizzi MR
    Antimicrob Agents Chemother; 1996 Feb; 40(2):325-30. PubMed ID: 8834874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Michel MF
    Antimicrob Agents Chemother; 1986 Sep; 30(3):403-8. PubMed ID: 3535664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of cefpirome (HR 810) and other cephalosporins on experimentally induced pneumonia in mice.
    Klesel N; Isert D; Limbert M; Seibert G; Winkler I; Schrinner E
    J Antibiot (Tokyo); 1986 Jul; 39(7):971-7. PubMed ID: 3531131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1019-25. PubMed ID: 1839380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of mathematical model to experimental chemotherapy of fatal murine pneumonia.
    Hishikawa T; Kusunoki T; Tsuchiya K; Uzuka Y; Sakamoto T; Nagatake T; Matsumoto K
    Antimicrob Agents Chemother; 1990 Feb; 34(2):326-31. PubMed ID: 2183718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protein binding in serum on therapeutic efficacy of cephem antibiotics.
    Tawara S; Matsumoto S; Kamimura T; Goto S
    Antimicrob Agents Chemother; 1992 Jan; 36(1):17-24. PubMed ID: 1590685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia.
    Hsieh CC; Lee CH; Hong MY; Hung YP; Lee NY; Ko WC; Lee CC
    Int J Antimicrob Agents; 2016 Dec; 48(6):712-718. PubMed ID: 27836382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia.
    Mandell LA; Nicolle LE; Ronald AR; Duperval R; Robson HG; Feld R; Vincelette J; Fong I
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():9-20. PubMed ID: 6352661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.